$1.4M Round of Financing

Bone Biologics Completes $1.4 Million Round of Financing

August 22, 2017 BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics (OTC: BBLG), a developer of orthobiologic products for domestic and international spine fusion markets,…